Distinct Roles of Adenovirus Vector-Transduced Dendritic Cells, Myoblasts, and Endothelial Cells in Mediating an Immune Response against a Transgene Product

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Virology

• Publication date

  2002-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.76.6.2899-2911.2002PMID 11861857PMCID PMC136003
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cross-presentation, dendritic cells, tolerance and immunity.

  2001cited by this paper
• Modulating the immune response with dendritic cells and their growth factors.

  2001cited by this paper
• Successful Interference with Cellular Immune Responses to Immunogenic Proteins Encoded by Recombinant Viral Vectors

  2001cited by this paper
• Internalization of Adenovirus by Alveolar Macrophages Initiates Early Proinflammatory Signaling during Acute Respiratory Tract Infection

  2000cited by this paper
• Murine dendritic cells infected with adenovirus vectors show signs of activation

  2000influential reference
• Consequences of cell death: exposure to necrotic tumor cells

  2000cited by this paper
• Adenoviral transduction of human 'clinical grade' immature dendritic cells enhances costimulatory molecule expression and T-cell stimulatory capacity.

  2000cited by this paper
• Consequences of Cell Death

  2000cited by this paper
• Immune Response to Recombinant Adenovirus in Humans: Capsid Components from Viral Input Are Targets for Vector-Specific Cytotoxic T Lymphocytes

  2000cited by this paper
• CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo.

  1999cited by this paper
• Direct and indirect T cell priming by dendritic cell vaccines

  1999cited by this paper
• Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens.

  1999cited by this paper
• Immunobiology of human vascular endothelium

  1999cited by this paper
• An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.

  1999influential reference
• Adenoviruses Activate Human Dendritic Cells without Polarization toward a T-Helper Type 1-Inducing Subset

  1999cited by this paper
• Enhanced immune response to the melanoma antigen gp100 using recombinant adenovirus-transduced dendritic cells.

  1999cited by this paper
• Immune Response to Recombinant Capsid Proteins of Adenovirus in Humans: Antifiber and Anti-Penton Base Antibodies Have a Synergistic Effect on Neutralizing Activity

  1998cited by this paper
• Human endothelial cells effectively costimulate cytokine production by, but not differentiation of, naive CD4+ T cells.

  1998cited by this paper
• Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

  1998cited by this paper
• Adenovirus-mediated expression of a dominant negative mutant of p65/RelA inhibits proinflammatory gene expression in endothelial cells without sensitizing to apoptosis.

  1998cited by this paper
• Transduction of Dendritic Cells by DNA Viral Vectors Directs the Immune Response to Transgene Products in Muscle Fibers

  1998cited by this paper
• Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

  1998cited by this paper
• Cytotoxic T-Lymphocyte Target Proteins and Their Major Histocompatibility Complex Class I Restriction in Response to Adenovirus Vectors Delivered to Mouse Liver

  1998cited by this paper
• Macrophages and dendritic cells in normal and regenerating murine skeletal muscle

  1997cited by this paper
• Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products.

  1997cited by this paper
• Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors.

  1997cited by this paper
• The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites.

  1997cited by this paper
• Dendritic Cells Genetically Modified with an Adenovirus Vector Encoding the cDNA for a Model Antigen Induce Protective and Therapeutic Antitumor Immunity

  1997influential reference
• Requirement for Vα14 NKT Cells in IL-12-Mediated Rejection of Tumors

  1997cited by this paper
• Rapid Effector Function in CD8+ Memory T Cells

  1997cited by this paper
• Histochemical Staining Following LacZ Gene Transfer Underestimates Transfection Efficiency

  1997cited by this paper
• Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells.

  1997cited by this paper
• Efficacy of replication-defective adenovirus-vectored vaccines: protection following intramuscular injection is linked to promoter efficiency in muscle representative cells.

  1997cited by this paper
• The ups and downs of adenovirus vectors.

  1996cited by this paper
• Generation of MHC class I‐restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non‐muscle cells

  1996cited by this paper
• Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo.

  1996cited by this paper
• Major histocompatibility complex class II-expressing endothelial cells induce allospecific nonresponsiveness in naive T cells

  1996cited by this paper
• Gene vaccination with naked plasmid DNA: mechanism of CTL priming

  1996cited by this paper
• Cyclophosphamide Diminishes Inflammation and Prolongs Transgene Expression Following Delivery of Adenoviral Vectors to Mouse Liver and Lung

  1996cited by this paper
• The expanding universe of T-cell subsets: Th1, Th2 and more.

  1996cited by this paper
• Medullary thymic epithelial cells induce tolerance to intracellular proteins.

  1996cited by this paper
• Immune responses to transgene–encoded proteins limit the stability of gene expression after injection of replication–defective adenovirus vectors

  1996cited by this paper
• Effect of human cytokines (IFN-gamma, TNF-alpha, IL-1 beta, IL-4) on porcine endothelial cells: induction of MHC and adhesion molecules and functional significance of these changes.

  1996cited by this paper
• Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells.

  1996cited by this paper
• The ups and downs of adenovirus vectors.

  1996cited by this paper
• High-titer packaging cells producing recombinant retroviruses resistant to human serum

  1995cited by this paper
• Fibroblasts as efficient antigen-presenting cells in lymphoid organs.

  1995cited by this paper
• Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression.

  1995cited by this paper
• Long‐term humoral and cellular immunity induced by a single immunization with replication‐defective adenovirus recombinant vector

  1995cited by this paper
• The immunobiology of muscle.

  1994cited by this paper
• The use of DNA viruses as vectors for gene therapy.

  1994cited by this paper
• Proteolytic processing of ovalbumin and beta-galactosidase by the proteasome to a yield antigenic peptides.

  1994cited by this paper
• Cultured human myoblasts and myotubes show markedly different transducibility by replication-defective adenovirus recombinants.

  1994cited by this paper
• Proteolytic Processing of Ovalbumin and β-galactosidase by the Proteasome to Yield Antigenic Peptides

  1994cited by this paper
• Immortalization of multiple cell types from transgenic mice using a transgene containing the vimentin promoter and a conditional oncogene.

  1994cited by this paper
• Biological behavior of malignant melanoma cells correlated to their survival in vivo.

  1975cited by this paper

• Immune cell separation for cell therapy: A comprehensive review of techniques, and challenges.

  2026cites this paper
• The gut microbiota modifies antibody durability and booster responses after SARS-CoV-2 vaccination

  2024cites this paper
• In vivo tracking of adenoviral-transduced iron oxide-labeled bone marrow-derived dendritic cells using magnetic particle imaging

  2023cites this paper
• Human Adenovirus Type 26 Induced IL-6 Gene Expression in an αvβ3 Integrin- and NF-κB-Dependent Manner

  2022cites this paper
• Scientific premise for the involvement of neutrophil extracellular traps (NETs) in vaccine‐induced thrombotic thrombocytopenia (VITT)

  2021cites this paper
• Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways

  2021cites this paper
• Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic

  2021cites this paper
• Understanding Post Entry Sorting of Adenovirus Capsids; A Chance to Change Vaccine Vector Properties

  2021cites this paper
• Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunity

  2021cites this paper
• Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model

  2021cites this paper
• Adenoviral vector‐based platforms for developing effective vaccines to combat respiratory viral infections

  2021cites this paper
• Breaking Entry-and Species Barriers: LentiBOOST® Plus Polybrene Enhances Transduction Efficacy of Dendritic Cells and Monocytes by Adenovirus 5

  2021cites this paper
• Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines

  2020cites this paper
• Limited expression of non-integrating CpG-free plasmid is associated with increased nucleosome enrichment

  2020cites this paper
• Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection

  2020cites this paper
• Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection

  2020cites this paper
• Human Parainfluenza Virus Type 2 Vector Induces Dendritic Cell Maturation Without Viral RNA Replication/Transcription

  2013cites this paper
• Absence of vaccine-enhanced RSV disease and changes in pulmonary dendritic cells with adenovirus-based RSV vaccine

  2011cites this paper
• miRNA-mediated silencing in hepatocytes can increase adaptive immune responses to adenovirus vector-delivered transgenic antigens.

  2011cites this paper
• Liver-directed gene expression using recombinant AAV 2/8 vectors--a tolerogenic strategy for gene delivery?

  2010cites this paper
• The potential of a novel Adenovirus vector for vaccination.

  2010cites this paper
• Vacinação com a proteína 2 da superfície de amastigotas contra a infecção experimental pelo Trypanosoma cruzi: eficácia de diferentes estratégias vacinais e mecanismos de imunidade

  2009cites this paper
• Specific Induction of Tumor Neovasculature Death by Modified Murine PPE-1 Promoter Armed with HSV-TK

  2008cites this paper
• IMMUNIZATION WITH ADENOVIRUS ENCODING EXOGENOUS PrP PROLONGS ASYMPTOMATIC SURVIVAL OF MICE WITH BSE DISEASE

  2008cites this paper
• A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer

  2007cites this paper
• Adeno-Associated Virus Type 2 (AAV2) Capsid-Specific Cytotoxic T Lymphocytes Eliminate Only Vector-Transduced Cells Coexpressing the AAV2 Capsid In Vivo

  2007cites this paper
• 7 – Gene Therapy Approaches in Neurology

  2007cites this paper
• T-cell immunity generated by recombinant adenovirus vaccines

  2007cites this paper
• Development of immunostimulatory virotherapy using non-transmissible Sendai virus-activated dendritic cells.

  2007cites this paper
• Vectors and Gene Therapy

  2006cites this paper
• Vaccination with Replication-Deficient Recombinant Adenoviruses Encoding the Main Surface Antigens ofToxoplasma gondii Induces Immune Response and Protection Against Infection in Mice

  2006cites this paper
• Dendritic cells transduced with an adenovirus vector encoding interleukin-12 are a potent vaccine for invasive pulmonary aspergillosis

  2005cites this paper
• Immunotherapy of Cancer by Dendritic Cell-Targeted Gene Transfer

  2005cites this paper
• An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity.

  2004cites this paper
• Protein Transduction Domains Fused to Virus Receptors Improve Cellular Virus Uptake and Enhance Oncolysis by Tumor-Specific Replicating Vectors

  2004cites this paper
• Bases moléculaires des interactions des adénovirus avec la muqueuse intestinale

  2004cites this paper
• Specific antibodies modulate the interactions of adenovirus type 5 with dendritic cells.

  2004cites this paper
• Adenovirus fibre exchange alters cell tropism in vitro but not transgene-specific T CD8+ immune responses in vivo.

  2004cites this paper
• Modifying Adenoviral Vectors for Use as Gene-Based Cancer Vaccines

  2004cites this paper
• Vaccination with helper-dependent adenovirus enhances the generation of transgene-specific CTL

  2004cites this paper
• Impaired clearance of virus-infected hepatocytes in transgenic mice expressing the hepatitis C virus polyprotein.

  2004cites this paper
• Dendritic cells modulated by cytokine-expressing adenoviruses alleviate eosinophilia and airway hyperresponsiveness in an animal model of asthma.

  2004cites this paper
• Gene Therapy Applications to Cancer Treatment

  2003cites this paper
• The Maturation of Murine Dendritic Cells Induced by Human Adenovirus Is Mediated by the Fiber Knob Domain*

  2003cites this paper
• Antigen Expressing a Human Tumor-Associated Immunization with Dendritic Cells and Memory CTL Responses Generated by Provision of 4-1 BB Ligand Enhances Effector

  2003cites this paper
• Provision of 4-1BB Ligand Enhances Effector and Memory CTL Responses Generated by Immunization with Dendritic Cells Expressing a Human Tumor-Associated Antigen1

  2003cites this paper